Abstract:Biocatalytic racemization of open-chain and cyclic dialkyl-, alkyl-aryl-and diaryl-substituted acyloins was accomplished using whole resting cells of Lactobacillus paracasei DSM 20207. The mild (physiological) reaction conditions ensured the suppression of undesired side reactions, such as elimination or condensation. This novel biocatalytic isomerization protocol represents an essential tool for the deracemization of pharmacologically important building blocks.Keywords: acyloins; biotransformations; Lactobacillus; racemization Until recently, the entropy-driven isomerization of enantiomers -racemization -was generally considered as an unwanted side reaction rather than a synthetically useful transformation. As a consequence, the controlled racemization of organic compounds has been studied rather scarcely and the number of protocols available to date using mild reaction conditions is very small.[1]The importance of clean racemization processes for organic synthesis predominantly emerged from their key role in so-called deracemization processes, [2] which allow the transformation of a racemate into a single stereoisomeric product without the occurrence of an unwanted stereoisomer in 100% theoretical yield. Since the majority of chemical racemization protocols require harsh reaction conditions, they are incompatible with an (in-situ) enantioselective biocatalytic transformation. In contrast, enzymes are highly compatible with each other and biocatalytic racemization thus holds great potential. [3] We have recently shown that mandelate racemase [EC 5.1.2.2] from Pseudomonas putida ATCC 12633 is an excellent catalyst for the isomerization of a wide spectrum of b,g-unsaturated a-hydroxycarboxylic acids.[4] However, saturated (aliphatic) analogues were not accepted at all. This limitation was successfully overcome by the use of whole resting cells of Lactobacillus spp., which allowed the clean racemization of a wide range of aliphatic and aryl-aliphatic a-hydroxycarboxylic acids. [5] In order to broaden the portfolio of biocatalytic racemization, we envisaged to extend the substrate range towards other hydroxy-compounds -acyloins. Non-racemic a-hydroxy ketones [6] constitute popular building blocks for the synthesis vic-diols and amino alcohols through diastereoselective reduction/alkylation and reductive amination, respectively, with highly efficient chirality transfer.[7] Chemical racemization of acyloins usually proceeds through the corresponding enediol and thus predominantly features methods based on acid-or base-catalysis.[8] The latter are often plagued by elimination as a major side reaction due to the ease of formation of a resonance-stabilized conjugated enone. Our search for a biocatalytic racemization of acyloins was triggered by the speculative (but unproven) existence of an acetoin racemase [9] and benzoin racemase, respectively. [10] In order to cover a reasonably broad range of substrates, enantiopure acyloins 1 -6 bearing small and large groups at both ends were selected for our initial tests...